Frontlight ResearchEarly access
Sickle cell disease trials in Dominican Republic
1 of 2 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleStudy of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease
- Where
- Santo Domingo
- Age
- 2 years to 17 years
- People
- 100 worldwide
- Run by
- Sanofi
See details and how to joinNCT07247188